• A cross-over, pharmacokinetic pilot study (single oral dose) in humans compared an oil-based CoQ10 preparation to CoQ10 in the VESIsorb® delivery system and demonstrated a 308% increase in peak blood levels (Cmax) and a 622% increase in area under the curve (AUC(0-10 hr)), a measure of 10-hour bioavailability • In the same study, AUC(0-10 hr) values were 285% and 499% greater with VESIsorb® CoQ10 compared to two other solubilized, bio-enhanced preparations • Promotes enhanced absorption of ubiquinol* • Clinically studied for peak absorption of CoQ10* • Made with hypoallergenic ingredients